Skip to main content
Log in

Reproduktionsmedizin: Fortschritt wagen – Grenzen erkennen

Reproductive medicine: venture progress – recognize limits

  • Leitthema
  • Published:
Der Gynäkologe Aims and scope

Zusammenfassung

Das 1991 in Kraft getretene Embryonenschutzgesetz (ESchG) bietet den in Deutschland in der Reproduktionsmedizin tätigen Ärzten und Biologen den gesetzlichen Rahmen, in dem sie arbeiten dürfen. Ziel des Gesetzes ist der Schutz des Präimplantationsembryos und die Festlegung der Rahmenbedingungen zur Herbeiführung einer Schwangerschaft. Die rechtlichen Rahmenbedingungen sollten jedoch so gestaltet werden, dass Verfahren, die in anderen Staaten zulässig sind und zu einer Verbesserung der Kinderwunschbehandlung geführt haben, in geeigneter Weise auch in Deutschland auf der Basis eines möglichst breiten gesellschaftlichen Konsenses ermöglicht werden. Dem Gesundheitsschutz der werdenden Mutter muss ebenso wie dem Schutz des Embryos in ausgewogener Weise Rechnung getragen werden.

Abstract

The German embryo protection law (1991) regulates a range of practices related to reproductive medicine, such as the number of embryos which can be created by ART per treatment cycle, and also defines under what circumstances women may access IVF treatment. The aim of the law is to protect the human preimplantation embryo from misuse, such as cloning. However, protection of the human preimplantation embryo and appropriate reproductive medical care have to be balanced, allowing German patients access to new treatment options such as elective single embryo transfer, which involves embryo selection and embryo cryopreservation. The authors call for a change in ART policy, and a modernized, comprehensive regulation of reproductive medicine in Germany.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8

Notes

  1. Das ESchG bestraft die Absicht, auch wenn die Tat nicht vollendet wurde. Als „Unternehmen“ gilt bereits der Versuch der Tat (§ 11 Abs. 1 Nr. 6 StGB). Der Versuch setzt die Absicht voraus, die Tat zu vollenden. Diesen Willen hat nicht, wer von vorneherein plant, den Befruchtungsvorgang im Vorkernstadium zu unterbrechen (etwa durch Kryokonservierung). Der Vorgang des Auftauens stellt dann eine erneute „Unternehmung“ der Befruchtung einer Eizelle dar, mit den Beschränkungen des § 1 Abs. 1 Nrn. 3 und 5, da beim Auftauen ein Embryo entsteht.

  2. Nach Ziff. 5.1 der Richtlinie der BÄK zur Durchführung der assistierten Reproduktion sollen Patientinnen unter 38 Jahren im ersten und zweiten IVF- oder ICSI-Versuch nur zwei Embryonen transferiert werden. Wünscht das Paar den Transfer von drei Embryonen, ist eine ausführliche Information und Aufklärung über das erhöhte Risiko für höhergradige Mehrlingsschwangerschaften und die damit verbundenen Risiken ärztliche Pflicht.

Literatur

  1. Witsenburg C et al. (2005) Cumulative live birth rates in cohorts of patients treated with in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 84(1): 99–107

    Article  PubMed  Google Scholar 

  2. Schröder AK et al. (2004) Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online 8(5): 600–606

    PubMed  Google Scholar 

  3. Doyle P (1996) The outcome of multiple pregnancy. Hum Reprod 11(Suppl) 4: 110–117

    PubMed  Google Scholar 

  4. Senat MV et al. (1998) How does multiple pregnancy affect maternal mortality and morbidity? Clin Obstet Gynecol 41(1): 78–83

    Article  PubMed  CAS  Google Scholar 

  5. Petridou E et al. (1996) Risk factors for cerebral palsy: a case-control study in Greece. Scand J Soc Med 24(1): 14–26

    PubMed  CAS  Google Scholar 

  6. Luke B, Keith LG (1992) The contribution of singletons, twins and triplets to low birth weight, infant mortality and handicap in the United States. J Reprod Med 37(8): 661–666

    PubMed  CAS  Google Scholar 

  7. Powers WF, Kiely JL (1994) The risks confronting twins: a national perspective. Am J Obstet Gynecol 170(2): 456–461

    PubMed  CAS  Google Scholar 

  8. Gardner MO et al. (1995) The origin and outcome of preterm twin pregnancies. Obstet Gynecol 85(4): 553–557

    Article  PubMed  CAS  Google Scholar 

  9. Sheard C et al. (2007) Impact of a multiple, IVF birth on post-partum mental health: a composite analysis.Hum Reprod 22(7): 2058–2065

    Article  PubMed  CAS  Google Scholar 

  10. Holte J et al. (2007) Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval. Hum Reprod 22(2): 548–557

    Article  PubMed  CAS  Google Scholar 

  11. Arce JC et al. (2006) Interobserver agreement and intraobserver reproducibility of embryo quality assessments. Hum Reprod 21(8): 2141–2148

    Article  PubMed  Google Scholar 

  12. Sjöblom P et al. (2006) Prediction of embryo developmental potential and pregnancy based on early stage morphological characteristics. Fertil Steril 86(4): 848–861

    Article  PubMed  Google Scholar 

  13. Griesinger G et al. (2005) Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum Reprod 20(5): 1200–1206

    Article  PubMed  CAS  Google Scholar 

  14. Zollner KP et al. (2002) First experiences with human blastocyst culture after IVF/ICSI under the conditions of the German embryo protection law. Zentralbl Gynakol 124(3): 164–169

    Article  PubMed  CAS  Google Scholar 

  15. Guerif F et al. (2007) Limited value of morphological assessment at days 1 and 2 to predict blastocyst development potential: A prospective study based on 4042 embryos. Hum Reprod 22(7): 1973–1981

    Article  PubMed  CAS  Google Scholar 

  16. Nicoli A et al. (2007) Limited importance of pre-embryo pronuclear morphology (zygote score) in assisted reproduction outcome in the absence of embryo cryopreservation. Fertil Steril 88(4 Suppl): 1167–1173

    Article  PubMed  Google Scholar 

  17. Ludwig AK et al. (2006) The value of pronuclear scoring for the success of IVF and ICSI-cycles. Arch Gynecol Obstet 273(6): 346–354

    Article  PubMed  CAS  Google Scholar 

  18. Papanikolaou EG et al. (2008) Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. Hum Reprod 23(1): 91–99

    Article  PubMed  Google Scholar 

  19. Blake DA et al. (2007) Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev (4): CD002118

    Google Scholar 

  20. Hassold TJ (1985) The origin of aneuploidy in humans. Basic Life Sci 36:103–115

    PubMed  CAS  Google Scholar 

  21. Boué A et al. (1985) Cytogenetics of pregnancy wastage. Adv Hum Genet 14: 1–57

    PubMed  Google Scholar 

  22. Staessen C et al. (2004) Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 19(12): 2849–2858

    Article  PubMed  Google Scholar 

  23. Mastenbroek S et al. (2007) In vitro fertilization with preimplantation genetic screening. N Engl J Med 357(1): 9–17

    Article  PubMed  CAS  Google Scholar 

  24. Collins JA (2007) Preimplantation genetic screening in older mothers. N Engl J Med 357(1): 61–63

    Article  PubMed  CAS  Google Scholar 

  25. Donoso P, Devroey P (2007) PGD for aneuploidy screening: an expensive hoax? Best Pract Res Clin Obstet Gynaecol 21(1): 157–168

    Article  PubMed  Google Scholar 

  26. Rama Raju GA et al. (2007) Meiotic spindle and zona pellucida characteristics as predictors of embryonic development: a preliminary study using polscope imaging. Reprod Biomed Online 14(2): 166–174

    Article  Google Scholar 

  27. Cecconi S et al. (2001) Presence of a 31-kD protein band in human cumulus-corona radiata-conditioned media and pregnancy outcome. Fertil Steril 75(5): 966–972

    Article  PubMed  CAS  Google Scholar 

  28. Nyboe Andersen A et al. (2008) Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE. Hum Reprod 23: 756–771

    Article  Google Scholar 

  29. Saldeen P, Sundström P (2005) Would legislation imposing single embryo transfer be a feasible way to reduce the rate of multiple pregnancies after IVF treatment? Hum Reprod 20(1): 4–8

    Article  PubMed  Google Scholar 

  30. Karlström PO, Bergh C (2007) Reducing the number of embryos transferred in Sweden-impact on delivery and multiple birth rates. Hum Reprod 22(8): 2202–2207

    Article  PubMed  Google Scholar 

  31. Van Landuyt et al. (2006) New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate. Reprod Biomed Online 13(6): 765–771

    Article  Google Scholar 

  32. Pandian Z, Templeton A, Serour G, Bhattacharya S. Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod. 2005 Oct;20(10):2681-7

Download references

Interessenskonflikt

Der korrespondierende Autor gibt an, dass kein Interessenskonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Diedrich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diedrich, K., Griesinger, G. Reproduktionsmedizin: Fortschritt wagen – Grenzen erkennen. Gynäkologe 41, 683–693 (2008). https://doi.org/10.1007/s00129-008-2190-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-008-2190-0

Schlüsselwörter

Keywords

Navigation